Kurt Fernstrom
Examiner (ID: 5518, Phone: (571)272-4422 , Office: P/3711 )
Most Active Art Unit | 3711 |
Art Unit(s) | 3714, 3712, 3715, 3711 |
Total Applications | 2669 |
Issued Applications | 1756 |
Pending Applications | 157 |
Abandoned Applications | 755 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 14055463
[patent_doc_number] => 10232008
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-03-19
[patent_title] => Multi-purpose nutritional supplement composition
[patent_app_type] => utility
[patent_app_number] => 15/286400
[patent_app_country] => US
[patent_app_date] => 2016-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 6531
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15286400
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/286400 | Multi-purpose nutritional supplement composition | Oct 4, 2016 | Issued |
Array
(
[id] => 11393934
[patent_doc_number] => 20170014469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-19
[patent_title] => 'METHODS OF REACTIVATING A LATENT HUMAN IMMUNODEFICIENCY VIRUS'
[patent_app_type] => utility
[patent_app_number] => 15/281672
[patent_app_country] => US
[patent_app_date] => 2016-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5816
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15281672
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/281672 | METHODS OF REACTIVATING A LATENT HUMAN IMMUNODEFICIENCY VIRUS | Sep 29, 2016 | Abandoned |
Array
(
[id] => 15381845
[patent_doc_number] => 10532081
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-14
[patent_title] => Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
[patent_app_type] => utility
[patent_app_number] => 15/258786
[patent_app_country] => US
[patent_app_date] => 2016-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20986
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15258786
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/258786 | Method of ameliorating or preventing the worsening or the progression of symptoms of BPH | Sep 6, 2016 | Issued |
Array
(
[id] => 13383657
[patent_doc_number] => 20180243370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => METHODS AND COMPOSITIONS FOR TREATMENT OF GAUCHER DISEASE VIA MODULATION OF C5A RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 15/758016
[patent_app_country] => US
[patent_app_date] => 2016-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15758016
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/758016 | METHODS AND COMPOSITIONS FOR TREATMENT OF GAUCHER DISEASE VIA MODULATION OF C5A RECEPTOR | Aug 28, 2016 | Abandoned |
Array
(
[id] => 12924718
[patent_doc_number] => 09827286
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-28
[patent_title] => Use of melanocortins to treat insulin sensitivity
[patent_app_type] => utility
[patent_app_number] => 15/242866
[patent_app_country] => US
[patent_app_date] => 2016-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 16149
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15242866
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/242866 | Use of melanocortins to treat insulin sensitivity | Aug 21, 2016 | Issued |
Array
(
[id] => 14746767
[patent_doc_number] => 20190256557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => POLYMYXIN B SULFATE CRYSTAL AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/326586
[patent_app_country] => US
[patent_app_date] => 2016-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16326586
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/326586 | POLYMYXIN B SULFATE CRYSTAL AND PREPARATION METHOD THEREOF | Aug 18, 2016 | Abandoned |
Array
(
[id] => 11323834
[patent_doc_number] => 20160354446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => 'Formulation for Regeneration of Bone, Cartilage, Teeth, and Periodontium and Treatment of Tumors and Cysts'
[patent_app_type] => utility
[patent_app_number] => 15/238292
[patent_app_country] => US
[patent_app_date] => 2016-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 15385
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15238292
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/238292 | Formulation for regeneration of bone, cartilage, teeth, and periodontium and treatment of tumors and cysts | Aug 15, 2016 | Issued |
Array
(
[id] => 12526950
[patent_doc_number] => 10005826
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-26
[patent_title] => Compounds that bind to the erythropoietin receptor
[patent_app_type] => utility
[patent_app_number] => 15/235321
[patent_app_country] => US
[patent_app_date] => 2016-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11455
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15235321
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/235321 | Compounds that bind to the erythropoietin receptor | Aug 11, 2016 | Issued |
Array
(
[id] => 11469684
[patent_doc_number] => 20170056466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-02
[patent_title] => 'Novel JNK inhibitor Molecules for Treatment of Various Diseases'
[patent_app_type] => utility
[patent_app_number] => 15/217326
[patent_app_country] => US
[patent_app_date] => 2016-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 31300
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15217326
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/217326 | JNK inhibitor molecules for treatment of various diseases | Jul 21, 2016 | Issued |
Array
(
[id] => 14948353
[patent_doc_number] => 10435435
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-08
[patent_title] => Quinstatin compounds
[patent_app_type] => utility
[patent_app_number] => 15/747077
[patent_app_country] => US
[patent_app_date] => 2016-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20214
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747077
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/747077 | Quinstatin compounds | Jul 21, 2016 | Issued |
Array
(
[id] => 12908932
[patent_doc_number] => 20180194819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => NOVEL BINDING PROTEINS BASED ON DI-UBIQUITIN MUTEINS AND METHODS FOR GENERATION
[patent_app_type] => utility
[patent_app_number] => 15/744054
[patent_app_country] => US
[patent_app_date] => 2016-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15215
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15744054
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/744054 | Binding proteins based on di-ubiquitin muteins and methods for generation | Jul 18, 2016 | Issued |
Array
(
[id] => 11670021
[patent_doc_number] => 20170158735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'METHOD FOR PRODUCING A RECOMBINANT PEPTIDE AND RESULTANT PEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 15/213039
[patent_app_country] => US
[patent_app_date] => 2016-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 65716
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15213039
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/213039 | METHOD FOR PRODUCING A RECOMBINANT PEPTIDE AND RESULTANT PEPTIDE | Jul 17, 2016 | Abandoned |
Array
(
[id] => 11437344
[patent_doc_number] => 20170038365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'SMALL MOLECULE INHIBITORS OF 8-OXOGUANINE DNA GLYCOSYLASE-1 (OGG1)'
[patent_app_type] => utility
[patent_app_number] => 15/213124
[patent_app_country] => US
[patent_app_date] => 2016-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12789
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15213124
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/213124 | SMALL MOLECULE INHIBITORS OF 8-OXOGUANINE DNA GLYCOSYLASE-1 (OGG1) | Jul 17, 2016 | Abandoned |
Array
(
[id] => 12904723
[patent_doc_number] => 20180193416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF METABOLIC DISORDERS USING SLIT2
[patent_app_type] => utility
[patent_app_number] => 15/741326
[patent_app_country] => US
[patent_app_date] => 2016-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58862
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -53
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15741326
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/741326 | Methods for identification, assessment, prevention, and treatment of metabolic disorders using Slit2 | Jul 14, 2016 | Issued |
Array
(
[id] => 11528614
[patent_doc_number] => 20170088591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'MODIFIED ANTIBIOTIC PEPTIDES HAVING VARIABLE SYSTEMIC RELEASE'
[patent_app_type] => utility
[patent_app_number] => 15/207117
[patent_app_country] => US
[patent_app_date] => 2016-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14660
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15207117
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/207117 | Modified antibiotic peptides having variable systemic release | Jul 10, 2016 | Issued |
Array
(
[id] => 13297589
[patent_doc_number] => 20180200331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => BST-2 AS A THERAPEUTIC TARGET AND DIAGNOSTIC MARKER FOR BREAST CANCER GROWTH AND METASTASIS
[patent_app_type] => utility
[patent_app_number] => 15/743324
[patent_app_country] => US
[patent_app_date] => 2016-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31833
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15743324
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/743324 | BST-2 AS A THERAPEUTIC TARGET AND DIAGNOSTIC MARKER FOR BREAST CANCER GROWTH AND METASTASIS | Jul 10, 2016 | Abandoned |
Array
(
[id] => 11382874
[patent_doc_number] => 20170008928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-12
[patent_title] => 'NOVEL PEPTIDES AND PEPTIDE DERIVATIVES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/202696
[patent_app_country] => US
[patent_app_date] => 2016-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55535
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15202696
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/202696 | NOVEL PEPTIDES AND PEPTIDE DERIVATIVES AND USES THEREOF | Jul 5, 2016 | Abandoned |
Array
(
[id] => 16841722
[patent_doc_number] => 11013781
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-25
[patent_title] => Peptide combinations and uses thereof for treating grass allergy
[patent_app_type] => utility
[patent_app_number] => 15/739440
[patent_app_country] => US
[patent_app_date] => 2016-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 21
[patent_no_of_words] => 93127
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15739440
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/739440 | Peptide combinations and uses thereof for treating grass allergy | Jun 30, 2016 | Issued |
Array
(
[id] => 11059885
[patent_doc_number] => 20160256846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-08
[patent_title] => 'METHODS OF LOCALIZING NUCLEIC ACIDS TO ARRAYS'
[patent_app_type] => utility
[patent_app_number] => 15/162304
[patent_app_country] => US
[patent_app_date] => 2016-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21629
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15162304
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/162304 | Methods of localizing nucleic acids to arrays | May 22, 2016 | Issued |
Array
(
[id] => 11350234
[patent_doc_number] => 20160368975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF BETA-THALASSEMIA'
[patent_app_type] => utility
[patent_app_number] => 15/161603
[patent_app_country] => US
[patent_app_date] => 2016-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12552
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15161603
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/161603 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF BETA-THALASSEMIA | May 22, 2016 | Abandoned |